Tonight:
5°c
380 jobs set to go at drugs giant
9 Feb 2010- Rangers FC appoints administrator
- Inflation plunges to 14-month low
- Solo Kate in Valentine's city visit
- Qatada deportation talks continue
- Perjury file over Lawrence trial
- Care probe hospital suspends staff
- £500,000 seized from canoeist wife
- Whitney funeral at childhood church
- Most hate crimes feature racism
- Bangkok bomber injured in own blast
Drugs giant GlaxoSmithKline is to cut up to a third of jobs at one of its UK research and development sites.
A 90-day consultation has started with workers at the site in Harlow, Essex, which employs 1,150, raising the threat of up to 380 job losses.
The company reported a 12% rise in annual profits last week but stressed the need to reduce costs, reviving fears of big job cuts.
Pre-tax profits for 2009 were £8.73 billion, but the firm announced plans to expand its restructuring programme to deliver another £500 million of savings by 2012.
Chief executive Andrew Witty said last week: "I believe that our strategy is delivering and GSK's long-term prospects are improving."
